Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.

Also called NCT03231982

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03231982
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03231982. Randomized; quadruple masking; primary purpose treatment. Start 2017-04-17 (actual); primary completion 2019-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan
Acronym
MACH
Condition
Hypertension
Intervention (Drug)
Group I
Intervention (Drug)
Group II
Lead sponsor
HK inno.N Corporation (class: industry)

Record details

Record id
cardio:ct-nct03231982
Content hash
26dabed1ce6764c30b538f64fbc460419539ac9fd21b53db19df9bbfbe0bb295